Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Alimentary Pharmacology & Therapeutics|April 9, 2020
Pregnancy outcomes in women with inflammatory bowel disease: a 10-year nationwide population-based cohort studyHan H Lee, Jung Min Bae, Bo-In Lee, et al.
Cell|July 3, 2007
A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system developmentIvan P G Moskowitz, Jae B Kim, Meredith L Moore, et al.
Molecular Therapy Oncolytics|July 23, 2020
Autologous Transplantation Using Donor Leukocytes Loaded Ex Vivo with Oncolytic Myxoma Virus Can Eliminate Residual Multiple MyelomaNancy Y Villa, Masmudur M Rahman, Joseph Mamola, et al.
Hypertension (Dallas, Tex. : 1979)|April 30, 2019
Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver AngiotensinogenEstrellita Uijl, Katrina M Mirabito Colafella, Yuan Sun, et al.
Nature Genetics|March 1, 2005
Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing lossJost Schönberger, Libin Wang, Jordan T Shin, et al.
Clinical Science (London, England : 1979)|January 6, 2021
No evidence for brain renin-angiotensin system activation during DOCA-salt hypertensionEstrellita Uijl, Liwei Ren, Katrina M Mirabito Colafella, et al.
European Heart Journal|March 7, 2014
Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trialsEvan A Stein, Robert P Giugliano, Michael J Koren, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 17, 2020
Efficacy of modified radical prostatectomy technique for recovery of urinary incontinence in high-grade prostate cancerJae W Chung, Sang W Kim, Ho W Kang, et al.
The New England Journal of Medicine|April 1, 2014
A 52-week placebo-controlled trial of evolocumab in hyperlipidemiaDirk J Blom, Tomas Hala, Michael Bolognese, et al.
Hypertension (Dallas, Tex. : 1979)|March 15, 2021
Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney DiseaseDominique M Bovée, Liwei Ren, Estrellita Uijl, et al.
Pageof 5